Dr Steven Chatfield

With over 40 years of experience in the Life Sciences Industry, he has spent much of his career in R&D, executive and advisory board roles within the private and public healthcare sector.

Dr Chatfield works as a consultant to the Biopharma industry and has a proven track record of success through all stages of product discovery and development leading to registration, and has provided expert advice on vaccines, vaccination and public health issues, including biodefence.

With his extensive knowledge of the vaccine industry, and his leadership role as Non-Executive Chairman, he will guide us through first-in-human clinical trials of SPVX02 (Tetanus diphtheria) and SPVX06 (Tetanus mono) vaccines.